Routine microbiological screening in septic patients in a cardiac surgical intensive care unit

D Meininger1, C Byhahn, D Maeser

  • 1Department of Anesthesiology, Intensive Care Medicine and Pain Control, JW Goethe-University Hospital, Frankfurt, Germany.

Abstract

Insights

Routine nose/throat swabs in surgical intensive care units (ICUs) have limited value for early sepsis treatment. While specific, their low sensitivity means many infections are missed, delaying appropriate antibiotic therapy.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Surgical intensive care unit (ICU) patients face high rates of nosocomial infections, often progressing to septic shock and mortality.
  • Early identification of causative agents is crucial for effective antibiotic treatment, but can be challenging.

Purpose of the Study:

  • To evaluate the utility of routine nose/throat swabs in guiding early, specific antibiotic therapy for patients with systemic inflammation in a cardiac surgical ICU.

Main Methods:

  • Routine nose/throat swabs were collected thrice weekly from 1435 cardiac surgical ICU patients.
  • Microorganisms and systemic inflammation were assessed; blood cultures were also obtained.
  • Antibiotic treatment was guided by swab results or administered empirically if swabs were negative.

Main Results:

  • Of 86 patients with systemic inflammation, 29 had positive blood cultures.
  • Only 11 patients had matching microbes on both routine swabs and blood cultures.
  • Routine swabs showed high specificity for sepsis but low sensitivity, limiting their screening utility.

Conclusions:

  • Routine nose/throat swabs facilitated earlier specific antibiotic treatment in only 22% of patients with systemic inflammation.
  • In 36% of cases, organisms from swabs and blood cultures did not match.
  • The study concludes that routine swabs have limited value for initiating early, specific antibiotic therapy in septic patients.